- Research article
- Open Access
Expression of antisense small RNAs in response to stress in Pseudomonas aeruginosa
BMC Genomicsvolume 15, Article number: 783 (2014)
RNA sequencing technologies reveal that bacteria express RNA molecules other than mRNA, rRNA or tRNA. During the last years genome-wide bacterial transcriptomes have been shown to comprise intergenic RNA, antisense RNA, and untranslated regions, all capable of performing diverse regulatory functions.
In this study we used RNA-seq to identify 232 antisense RNAs (asRNAs) in the opportunistic pathogen Pseudomonas aeruginosa grown under 13 different conditions. The conditions studied include exponential and stationary growth as well as osmotic, oxidative and antibiotic stress. We found a significant overrepresentation of asRNAs that are transcribed opposite to genes involved in cell division and in cell wall, lipopolysaccharide (LPS), and capsule biosynthesis, most likely reflecting the conditions used in this study. A substantial number of asRNAs significantly changed their expression under osmotic, oxidative and antibiotic stress, suggesting that asRNAs may play regulatory roles during these conditions. We also made a comparison between the asRNAs detected in this study in P. aeruginosa PAO1 with the asRNAs detected in two previous studies in P. aeruginosa PA14, and found that the extent of overlap between the studies is very limited.
RNA-seq experiments are revealing hundreds of novel transcripts in all bacterial genomes investigated. The comparison between independent studies that used RNA-seq to detect novel asRNAs in P. aeruginosa shows that the overlap between the results reported is very narrow. It is necessary to address how reproducibility of these kind of studies should be reported in order to avoid misleading conclusions when comparing data generated by non-identical methods.
During the last years an increasing number of bacterial transcriptomes have been examined with tiling arrays and RNA sequencing (RNA-Seq) technologies, revealing that a significant number of protein-coding genes are also transcribed from the reverse complementary strand in a wide range of bacterial species [1–8]. Overlapping transcription results in the generation of antisense RNAs (asRNA) with sizes ranging from tens to thousands of nucleotides (nt). Regulatory roles of asRNAs were first reported more than 30 years ago in Escherichia coli, where plasmid-encoded asRNAs were found to negatively regulate plasmid copy number [9–11]. Since then bacterial asRNAs were only occasionally detected and therefore considered to be rare, and as late as in 2007 only about thirty bacterial asRNAs had been identified (reviewed in ). However, due to the use of tiling array and especially RNA-Seq the number of reported asRNAs in bacterial transcriptomes is now rapidly growing. The characterization of the physiological function of individual asRNAs is however lagging behind. AsRNAs are known to affect the expression of the target gene by different mechanisms (reviewed in ). These include: (i) interference by convergent transcription, in which transcription from one promoter is suppressed by a second promoter located in the opposite strand, (ii) transcription attenuation, in which base pairing of the asRNA to the target mRNA causes premature transcription termination, (iii) changes in the target RNA stability, where the asRNA either promotes or blocks degradation or cleavage of the mRNA by ribonucleases, (iv) asRNAs can directly block ribosome binding, and (v) might indirectly impact ribosome binding (either positively or negatively) by affecting the target RNA structure. In addition, regulating the expression of the opposite gene is not the only function of certain asRNAs. Some asRNAs encode small proteins , and some have the potential to act on multiple targets in trans[15–19].
In this work, we used RNA-Seq to identify asRNAs in the human pathogen P. aeruginosa, which can cause severe infections, particularly in immunocompromised and cystic fibrosis (CF) patients. The CF lung is an osmotically stressful environment, due to the viscous, dehydrated mucus, cellular debris and electrolytes competing for a limited supply of water [20, 21]. A variety of studies have shown that P. aeruginosa encounters reactive oxygen species (ROS) in the lungs of CF patients due to the exaggerated, sustained and extended inflammatory response, characterized by influx of neutrophils and high concentrations of interleukin-8 [22–24]. In addition, P. aeruginosa-infected CF patients are routinely treated with several types of antibiotics, because early and aggressive antipseudomonal treatment regimens are correlated with improved lung function and survival of CF patients . Recently, two independent studies identified antisense transcription in P. aeruginosa. One of the studies investigated strains PAO1 and PA14 at early stationary growth phase and found 60 asRNAs, of which 19 were expressed in strain PAO1 . The other study identified 384 antisense transcriptional start sites, but not full length asRNAs, in P. aeruginosa PA14 grown at 28°C and at 37°C . The expression of asRNAs most likely occurs in a transient manner and is dependent on specific environmental cues. Therefore, we chose to monitor the expression of asRNAs in P. aeruginosa PAO1 grown in several different conditions to ensure a comprehensive characterization of the P. aeruginosa asRNA-ome. Accordingly, exponentially growing populations of P. aeruginosa PAO1 were exposed to osmotic, oxidative and antibiotic stress. The antibiotics used in this study were ß-lactams, aminoglycosides, macrolides, colistin and tetracycline. All the antibiotics used, with the exception of tetracyclin, are routinely used against P. aeruginosa infections [28–32]. Finally, the expression of asRNAs was also investigated during exponential and stationary growth.
Recently, we showed that library preparation for RNA-Seq plays a fundamental role when aiming at identifying novel transcripts . Using three different RNA-Seq library protocols with different sRNA abundance, we identified over 500 novel intergenic sRNAs in P. aeruginosa PAO1 [33, 34]. Although the use of three different libraries increased the number of novel transcripts identified, there were significant differences in the subset of transcripts detected in each library. Libraries that were prepared with a size-selected fraction of RNA were more sensitive in the detection of intergenic sRNAs . In the present study we report 232 novel asRNAs that were identified using strand-specific RNA-Seq libraries that contain cDNA originating from transcripts shorter than 500 nt [33, 34].
Results and discussion
Antisense RNAs detection and classification
Exponentially growing cells of P. aeruginosa PAO1 were exposed to sodium chloride (NaCl) and hydrogen peroxide (H2O2) inducing osmotic and oxidative stress conditions, respectively. The antibiotics used were piperacillin, ceftazidime, aztreonam, meropenem, tobramycin, azithromycin, colistin and tetracycline. The concentrations of antibiotics, NaCl and H2O2 are shown in Table 1. RNA-Seq libraries were prepared using the previously described protocol LIB < 500, which produces strand-specific libraries that contain cDNA originating from transcripts shorter than 500 nt [33, 34]. On average 2.6% of the mapped reads covered regions antisense to previously annotated transcripts (Additional file 1).
In total, we identified 232 novel asRNAs longer than 50 nt, of which 212 are novel transcripts. The 22 asRNAs already identified by other studies are listed in Tables 2 and 3. Additional file 2 lists the coordinates of the 232 asRNAs, as well as the annotation of genes transcribed from the opposite strand. Only asRNAs longer than 50 nt were taken into consideration. The longest detected asRNA is 581-nt long. The asRNAs were categorized depending on their position with respect to the antisense gene as “start-span” (the asRNA overlaps with the 5’ end of the antisense gene), “internal” (the asRNA starts and ends within the antisense gene), or “end-span” (the asRNA overlaps with 3’ the end of the gene). Thirteen asRNAs overlapped with two contiguous genes transcribed from the opposite strand. Some genes have untranslated regions (UTRs) either in the 5’ or the 3’ end which can contain regulatory elements for controlling gene expression. UTRs sometimes extend into the neighboring genes, so we cannot rule out that some of the detected asRNAs might actually be UTRs from neighboring genes. To prevent mis-annotation of UTRs as asRNAs, we have not included asRNAs that terminated less than 100 bp to the start of a flanking gene with the same direction as the asRNA. However we cannot rule out that some of the novel asRNAs identified in this study might be long UTRs belonging to flanking genes, or even novel coding genes. It is also possible that some of the asRNAs identified are the result of non-specific transcription and thus have no physiological functions.
Next, we examined the distribution of antisense sRNAs in the genome and found the asRNAs to be homogenously distributed throughout the genome of P. aeruginosa PAO1 (Figure 1A). A recent study by Wurtzel et al. found that antisense sRNAs are more often found in some parts of the accessory genome of P. aeruginosa PA14 . Specifically, the authors identified 384 sites with overlapping transcription on the reverse strand, and found that the pathogenicity island PAPI-1 harbors 5-fold more asRNA loci compared to the core genome. In this study we do not observe a similar enrichment of antisense transcripts in certain parts of the genome. There are two reasons that might explain the difference between this study and the one from Wurtzel et al. (2012). i) The strain used in the study is P. aeruginosa PAO1, while Wurtzel et al. (2012) used strain PA14. The PAPI-1 island is found in strain PA14 but not in PAO1, though it can be transferred by a type IV pilus . ii) Wurtzel et al. (2012) studied two conditions (growth at 28°C and at 37°C, respectively). In this study we sequenced samples from P. aeruginosa growing in 12 different conditions. Studying more conditions might lead to finding antisense transcription sites in more genomic locations, and therefore avoiding enrichment of expression of asRNAs associated to a specific condition.
Functional classification and differential expression of asRNAs
Figure 1B shows the classification of genes with asRNAs transcribed from the reverse strand in our experiments according to their function. We found a significant overrepresentation of the classes ‘Cell division’ (3.4-fold increase, P = 0.03) and ‘Cell wall / LPS / capsule’ (2.2-fold increase, P = 0.003). This overrepresentation of genes involved in cell division and cell wall, lipopolysaccharide (LPS), and capsule biosynthesis most likely reflects the conditions used in this study. The conditions studied (stationary phase, osmotic, oxidative and antibiotic stresses) greatly affect both the bacterial replication and cell wall synthesis, and therefore fast regulation of the genes involved in these processes is essential. Indeed we observe significant changes in expression of cell division and LPS genes after the antibiotic treatments (data not shown), which is in agreement with previous studies . Interestingly we have detected 6 asRNAs (as138-as143) that are transcribed opposite to 7 genes of the wbp cluster (wbpBCDE, wzy, wbpG and wbpJ) (Additional file 3). The wbp cluster contains genes encoding proteins involved the B-band LPS O-antigen biosynthesis in P. aeruginosa, including genes for enzymes involved in synthesis and transfer of sugar nucleotides and O-antigen processing . WbpB, WbpE, and WbpD are the three central enzymes in this pathway . Cirz et al. (2006) reported that the transcription of wbp genes were decreased by 2- to 6-fold after exposure to ciprofloxacin . Our sequencing results originating from libraries containing the full transcriptome show the same trend after ciprofloxacin and tobramycin exposure, with down-regulation of the wbp genes of 2- to 15-fold, and down-regulation of the asRNAs as138-as143 of 2- to 10-fold. However further investigations are required to assess whether these asRNAs affect the levels of the wbp genes encoded on the opposite strand.
Figure 2A represents the number of asRNAs whose expression is significantly changed during the conditions tested (P < 0.01). A substantial number of asRNAs significantly change their expression, indicating that their putative regulatory effects may be important during the conditions tested. A hierarchical cluster analysis of expression of the most differentially expressed asRNAs illustrates how related conditions show similar patterns of asRNA expression (Figure 2B). The treatments with three of the β-lactams (CEF, PP, AZT), whose modes of action are alike, are clustered together. The β-lactam not clustered in this group is meropenem, a carbapenem which displays a much faster time-kill curve than the other three β-lactams tested (data not shown). Additional file 4 lists the asRNAs differentially transcribed in our conditions, as well as their fold-change in expression. We anticipate that these data will be important to understand the regulation of genes that show antisense transcription on the reverse strand. In most cases we do not observe a clear and significant correlation between the transcriptional levels of asRNAs and their target genes. This makes it difficult to infer the mode of action of asRNAs, and it might indicate that the role of most asRNAs is to fine-tune the regulation of gene expression. This is known to be the case for some sRNAs in Pseudomonas species [39, 40]. In addition asRNAs can regulate the translation of their target genes either positively or negatively, without affecting their transcriptional levels. Thus the level of expression alone cannot explain the mechanism of action of asRNAs, and more experiments will be needed in order to determine how asRNAs regulate their target genes.
Comparison between asRNAs detected in different studies
Recently two independent studies used RNA-Seq to investigate transcription in P. aeruginosa and revealed novel asRNAs. One of the studies investigated strains PAO1 and PA14 grown aerobically in Brain Heart Infusion (BHI) rich medium at 37°C and harvested at early stationary phase . The authors found 60 asRNAs. Interestingly, a number of these asRNAs were strain-specific or showed strain-specific expression: 19 asRNAs were only expressed in strain PAO1, 29 were only expressed in strain PA14, and 12 were expressed in both strains. The other study investigated P. aeruginosa PA14 grown aerobically at 28°C and at 37°C in LB medium and harvested at early stationary phase . The authors identified 384 transcription start sites with overlapping transcription on the reverse strand. However, due to their library preparation protocol, Wurtzel et al. (2012) could not determine the length of the asRNAs, but only the antisense transcription start sites . In this study, we identified 232 asRNAs with lengths ranging from 50 to 581 nt. We did not take into consideration neither asRNAs shorter than 50 nt, nor asRNAs that might be suspected to be UTRs of flanking genes. This might explain why we identify considerably fewer asRNAs than Wurtzel et al. (2012). Figure 3 represents the overlap between the asRNAs detected in this study and the two previous ones. Only a small partial overlap between studies is observed. The overlap between pairs of studies ranged from 7 to 11 asRNAs, and only four asRNAs were detected in all three studies (Tables 2, 3 and 4). These asRNAs are transcribed antisense to the glutathione synthetase gene gshB, the NADH dehydrogenase I chain A gene nuoA, the ribosome biogenesis GTP-binding protein YsxC gene ysxC, and the penicillin-binding protein 1A gene ponA. We have validated the expression of the latter asRNA, from now on called AsponA, using 5’- and 3’-RACE. The coordinates of asponA were very similar between the RNA-Seq data and the RACE experiments, with differences of up to 19 nt between the two techniques. AsponA is upregulated upon aztreonam (2.9-fold), piperacillin (2.8-fold), and ciprofloxacin (2-fold) exposure, and downregulated during meropenem (-2-fold), colistin (-3-fold), tobramycin (-5.4-fold), and tetracycline (-5.6-fold) exposure. AsponA overlaps with the predicted -10 and -35 σ70 promoter elements of the ponA gene (Additional file 5). Due to the location of AsponA, we hypothesized that it probably belongs to the class of asRNAs that prevent the transcription or translation of the opposite gene, either by transcription interference or by directly blocking ribosome binding. Wurtzel et al. (2012) and Ferrara et al. (2012) detected the expression of AsponA in P. aeruginosa PA14 and PAO1 [26, 27].
The lack of overlap between the reported asRNAs may be caused by the different characteristics of each work, as (i) different growth conditions, (ii) different P. aeruginosa strains, and (iii) different methods to perform RNA-seq were used in each of them. (i) The three studies investigated different P. aeruginosa strains (PAO1 and PA14) grown under different conditions, which may account for part of the differences in the asRNAs detected. As previously mentioned, the level of expression of asRNAs varies greatly that in the different conditions used in our experiments (Figure 2), and in consequence the asRNAs that are detected by RNA-Seq in each condition. (ii) The evolution of bacterial sRNAs appears to be rapid and, as a result, sequence similarities between sRNAs are limited, even between relatively closely related species . In a previous study we showed that, out of 513 novel intergenic sRNAs detected in P. aeruginosa PAO1, the sequences of 88% of the sRNAs are not conserved outside P. aeruginosa, indicating that the extent of conservation in other Pseudomonas species is limited . Ferrara et al. (2012) have reported that even under the same growth conditions, different strains of P. aeruginosa (PAO1 and PA14) express different sets of both intergenic and antisense sRNAs . However when comparing studies that investigated the same strain, the extent of the overlap is still small (Figure 3). We considered whether the expression of strain-specific asRNAs was due to the existence of antisense promoters that were present in only one of the two strains. However, upon examination of strain-specific asRNAs, we observed that the predicted antisense promoters were present in both strains even if antisense transcription was only detected in one of them. (iii) We hypothesize that the main cause for the limited overlap between the studies may be the biases arising from the technical variation between the studies. These three studies used considerably different RNA extraction methods, RNA-Seq library preparation protocols, sequencing platforms and bioinformatic analysis pipelines.
Library preparation for RNA-seq experiments requires multiple enzyme-catalyzed steps such as sequential oligonucleotide adapter ligations to the 5’and 3 ends of RNAs, reverse transcription (RT), and PCR. RNA ligase preferences may contribute to the observed bias in sRNA detection [42–45], as well as the RT reaction and PCR [46–48]. The biases in sRNA detection could even be caused by the use of different buffer compositions and additives that modify enzymatic activity. Hafner et al. (2011) investigated the biases associated to the adapter ligation steps involved RNA-seq library preparation . The biases found were mainly due to the sequences of RNAs, and that secondary and tertiary structures of RNAs affected the efficiency of 5’- and 3’-adapter ligation during library preparation. The sequences of 5’ and 3’ adapters were also found to affect the ligation yields . In line with these results, another study also demonstrated that RNA and RNA-adapter secondary structures drastically influences RNA ligation efficiencies . Another investigation reported that increased variability of adapter sequences helps to increase the diversity of RNAs ligated . Recent systematic investigations have revealed method-dependent biases in miRNA quantification [49, 50]. Based on identical starting material, these studies demonstrated that alternative library preparation methods resulted in entirely different miRNA expression levels. It was observed that the detection of miRNAs by RNA-seq was strongly biased towards certain miRNAs, preventing the accurate determination of absolute numbers of transcripts . However the biases were found to be systematic and highly reproducible and differential expression results between samples obtained by qPCR and RNA-seq were strongly correlated, showing that RNA-seq is suited for determining relative expression differences between samples . Unexpectedly, the observed bias was mostly independent of the sequencing platform but strongly determined by the method used for library preparation. Library replicates gave similar results, which indicates that the data bias was likely caused by differences inherent to the cDNA preparation protocols . In a previous study, we also generated different RNA-seq libraries to identify bacterial sRNAs . Two libraries only included the RNA fractions shorter than 500 nt and shorter than 200 nt, respectively. Another library contained information on the full transcriptome. Almost all previously known sRNAs and over 500 novel intergenic sRNAs were identified in P. aeruginosa with this approach. There were significant differences in the subset of transcripts detected in each library , and the libraries that did not include larger transcripts were clearly superior in detecting sRNAs. All these investigations underscore the importance of library preparation strategy and relative sRNA abundance for successful sRNA detection, and show that in order to increase the number of sRNAs detected it is required to apply different parallel sequencing strategies.
RNA-Seq was used to identify and quantify 232 asRNAs in the opportunistic pathogen P. aeruginosa growing under in 13 different conditions, including osmotic, oxidative and antibiotic stress, and exponential and early stationary phase. Due to our library preparation protocol, only asRNAs ranging approximately from 50 to 500 nt were detected. Thus the number of asRNAs provided in this study is most likely an underestimate as longer asRNAs have not been included. These data are important for the understanding of the regulation of genes that show antisense transcription on the reverse strand. However the large number of asRNAs detected makes it difficult to unravel functionality and physiological impacts of antisense transcription, and this paper should therefore be read as a documentation of the potential asRNA repertoire from which specific studies can be designed. In addition, we present data showing that in several cases growth conditions impact on the expression levels of asRNA, which suggest that at least some of the asRNAs may play roles in physiological adaptation to changing conditions. A significant number of asRNAs were transcribed opposite to genes involved in cell division and in cell wall, lipopolysaccharide (LPS), and capsule biosynthesis. A substantial number of antisense sRNAs significantly changed their expression during early stationary phase and under osmotic, oxidative and antibiotic stress, suggesting that asRNAs may play a regulatory role during these conditions.
Finally, we compare our results with those obtained by others in order to document that detection of these new types of potential regulatory molecules is not trivial and that choice of detection and documentation methods is truly important. One of the challenges of performing genome-wide expression studies of sRNAs is to compare the extremely large data sets resulting from different RNA-Seq studies, as library preparation protocols, sequencing platforms, and thresholds for detecting transcripts differ from study to study. Our comparison of three independent studies that used RNA-seq to detect novel asRNAs in P. aeruginosa shows that the extent of overlap between the results reported is very limited. It is necessary to address considerations like what is an appropriate threshold of reads for transcript detection, or how reproducibility should be reported in order to avoid misleading conclusions when comparing data generated by non-identical methods. In addition, public databases are already and will be needed for sharing, analyzing, and storing transcriptomic data. Apart from sharing and comparing RNA-seq data, the validation and functional characterization of the hundreds of novel sRNAs now being reported will also be a major challenge of current RNA research.
Growth in Luria–Bertani (LB) broth (250 rpm, 37°C) or on LB plates at 37°C was used throughout this study. Overnight cultures of Pseudomonas aeruginosa PAO1 were diluted to a starting OD600 of 0.01 and grown to an OD600 of 0.5, at which an antibiotic, 0.5 M NaCl or 1 mM hydrogen peroxide was added. The final concentrations of antibiotics are shown in Table 1. Concentrated stock solutions of H2O2 and all antibiotics were prepared fresh daily. Cells were harvested 1 hour after the addition of antibiotics, NaCl and H2O2. Early-stationary phase cells were harvested from cultures grown to an OD600 of 3. RNA was extracted and used to make RNA-Seq libraries LIB < 500 (described below). Experiments were performed in duplicates.
MIC value calculation
Minimum inhibitory concentrations (MIC) of P. aeruginosa PAO1 were assessed using both the broth microdilution procedure and E-test strips.
Broth microdilution. LB medium was added to all wells of a 96-well microtiter plate loaded with serially diluted antibiotics. Each well was inoculated with P. aeruginosa PAO1 at a final concentration of 5 × 105 cfu/ml. The plates were incubated for 24 hours (250 rpm, 37°C). Following incubation, the optical density of all wells was measured and the lowest concentration showing complete inhibition of growth was recorded as the MIC for that antibiotic. The experiments were performed in triplicates. Concentrated stock solutions of all antibiotics were prepared fresh daily.
E-Test. E-test (bioMérieux AB BIODISK) strips were used according to the manufacturer’s instructions. LB plates were inoculated equal amount of P. aeruginosa PAO1 cells. After drying, the E-test strips were placed on the top of the plates. The MIC values were read after 16 h of incubation at 37°C. The experiments were performed in triplicates.
Harvested cells were mixed immediately with 0.2 volumes of STOP solution (95% ethanol, 5% phenol) and pelleted by centrifugation. Total RNA was extracted with Trizol (Invitrogen). Removal of DNA was carried out by treatment with DNase I (Fermentas) in combination with the RNase inhibitor RiboLock (Fermentas). The integrity of total RNA and DNA contamination were assessed with an Agilent 2100 Bioanalyzer (Agilent Technologies).
Removal of 23S, 16S and 5S rRNAs
The 23S, 16S and 5S rRNAs were removed by subtractive hybridization using the MICROBExpress kit (Ambion) with modifications as previously described [33, 34]. Capture oligonucleotides complementary to the rRNAs of P. aeruginosa PAO1 were used (Additional file 6). Removal of rRNAs was confirmed with an Agilent 2100 Bioanalyzer (Agilent Technologies).
Library preparation and RNA sequencing
Sequencing libraries were constructed as previously described, following LIB < 500 and LIB > 100 protocols [33, 34]. Each type of library was prepared in duplicate using RNA extracted from biological replicates. Libraries LIB < 500 are strand-specific and contain cDNAs originating from transcripts shorter than 500 nt. Libraries LIB > 500 were used for asRNA detection. RNA size selection was performed by running total RNA on 10% polyacrylamide gels containing 10 M urea. Gel slices corresponding to RNAs up to 500 nt were excised, followed by elution of RNA in 0.4 M NaCl and precipitation with ethanol. The 5S rRNA was depleted as previously described, followed by treatment with Tobacco Acid Pyrophosphatase (Epicentre Technologies) at 37°C for 90 min. Tobacco Acid Pyrophosphatase (TAP) is used to convert 5’-triphosphate RNA into 5’-monophosphate RNA, which is important for correct adapter ligation. This was followed by treatment with RNase III (Ambion) for 10 min at 37°C to fragment the RNA. RNase III fragments RNA into smaller pieces containing a 5’-phosphoryl group and a 3’-hydroxyl group, which is important for specific adapter ligation in the next step. Sequential ligation of RNA 3’ and 5’ adapters was performed using the adapters and enzymes from the TruSeq Small RNA Sample Preparation kit (Illumina). Next, reverse transcription followed by PCR amplification was performed to form cDNA constructs based on the RNA fragments ligated with 3’ and 5’ adapters, selectively enriching fragments with adapter molecules on both ends. The reverse transcription and subsequent PCR amplification were performed using the enzymes and reagents from the TruSeq Small RNA Sample Preparation kit (Illumina). Libraries LIB > 100 contain cDNA from all RNAs transcribed with the exception of 23S, 16S and 5S rRNAs. This type of library was prepared using using the TruSeq RNA Sample Preparation kit (Illumina) following the manufacturer’s instructions. Agencourt AMPure XP beads (Beckman Coulter Genomics) were used for the post-PCR clean-up. After each step the samples were validated using an Agilent 2100 Bioanalyzer (Agilent Technologies), and the final concentration was measured using a Qubit 2.0 Fluorometer (Invitrogen). The libraries were sequenced using the Illumina HiSeq2000 platform with a paired-end protocol and read lengths of 100 nt.
Our analysis pipeline is described in detail in Gómez-Lozano et al. (2014) . Briefly, reads were mapped onto the P. aeruginosa PAO1 genome (RefSeq Accession No. NC_002516) using the Bowtie 2 short read aligner . Read alignments from Bowtie 2 were handled using SAMtools . Information about the number of reads of each library used for asRNA detection can be found in Additional file 1. In order to obtain normalized expression intensities of the read coverage depth at each position in the genome, the number of reads in each replicate was normalized according to the total number of reads in the library, and expression intensities from replicate samples were averaged. A custom-made script was designed to detect novel transcripts antisense to annotated genes (Additional file 7) . Only transcripts of at least 50 nt were considered further. The resulting transcripts from automatic classification were re-evaluated by visual inspection. An analysis of variance (ANOVA) was performed on the average expression of the transcripts to determine those with differential expression between the conditions tested (P-value <0.05 and fold change 2). Sequencing libraries LIB < 500 have been submitted to the European Nucleotide Archive under accession number PRJEB6998 (http://www.ebi.ac.uk/ena/data/view/PRJEB6998).
Rapid amplification of cDNA ends (RACE)
Additional file 6 lists primers and adapters used.
5’ RACE. 2 μg rRNA-depleted RNA was incubated with 10 U of Tobacco Acid Pyrophosphatase (Epicentre Technologies) at 37°C for 1 h to convert RNA 5’ triphosphates in 5’ monophosphates. The same amount of control RNA was incubated under the same conditions in the absence of the enzyme. Reactions were stopped by phenol-chloroform extraction, followed by etanol-sodium acetate precipitation. Precipitated RNAs were redissolved in water, mixed with 500 pmol of 5’ RNA adapter, heat-denatured at 95°C for 5 min, then quick-chilled on ice. A short RNA adapter was ligated was ligated with 50 U of T4 RNA ligase (Thermo Scientific) at 37°C for 1 h. Reactions were stopped by phenol-chloroform extraction, followed by ethanol–sodium acetate precipitation. Precipitated RNAs were re-dissolved in 20 μl water. Then 10 μl of 5’adapter-ligated RNA was reverse-transcribed using 2 pmol of primer complementary to the sRNA (5’-GSP1) and the Thermoscript RT-PCR system (Invitrogen) according to the manufacturer’s instructions. Reverse transcription (RT) was performed in three subsequent 20 min steps at 55°C, 60°C, and 65°C, followed by treatment with RNase H. Primers were removed using the NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel). The products of RT were amplified using 10 pmol of another primer complementary to the sRNA (5’-GSP2) and 10 pmol the 5’ adapter-specific primer, together with the Maxima Hot Start PCR Master Mix (Thermo Scientific) according to the manufacturer’s instructions. Negative controls were performed using the 5’ adapter-ligated RNA as template. The PCR products were resolved and purified using E-Gel SizeSelect 2% Agarose gels (Invitrogen). Products were sequenced with 5’-GSP2 and 5’ adapter-specific primers by LGC Genomics GmbH (Germany).
3’ RACE. 2 μg rRNA-depleted RNA was dephosphorylated with calf intestinal alkaline phosphatase (New England Biolabs) at 37°C for 1 h. Reactions were stopped by phenol-chloroform extraction, followed by etanol-sodium acetate precipitation. Ligation was done as above with a 3’ RNA adapter with a 3’-inverted deoxythymidine (3’-idT). RT was carried out as described, but with 10 pmol of a single primer complementary to the 3’ RNA adapter. PCR amplification, band purification and sequence analysis was done as described above. All enzymatic treatments of RNA were performed in the presence of 20 units of RiboLock RNase Inhibitor (Thermo Scientific).
Sharma CM, Hoffmann S, Darfeuille F, Reignier J, Findeiss S, Sittka A, Chabas S, Reiche K, Hackermüller J, Reinhardt R, Stadler PF, Vogel J: The primary transcriptome of the major human pathogen Helicobacter pylori. Nature. 2010, 464: 250-255. 10.1038/nature08756.
Toledo-Arana A, Dussurget O, Nikitas G, Sesto N, Guet-Revillet H, Balestrino D, Loh E, Gripenland J, Tiensuu T, Vaitkevicius K: The Listeria transcriptional landscape from saprophytism to virulence. Nature. 2009, 459: 950-956. 10.1038/nature08080.
Filiatrault MJ, Stodghill PV, Bronstein PA, Moll S, Lindeberg M, Grills G, Schweitzer P, Wang W, Schroth GP, Luo S, Khrebtukova I, Yang Y, Thannhauser T, Butcher BG, Cartinhour S, Schneider DJ: Transcriptome analysis of Pseudomonas syringae identifies new genes, noncoding RNAs, and antisense activity. J Bacteriol. 2010, 192: 2359-2372. 10.1128/JB.01445-09.
Guell M, Van Noort V, Yus E, Chen W-H, Leigh-Bell J, Michalodimitrakis K, Yamada T, Arumugam M, Doerks T, Kuhner S, Rode M, Suyama M, Schmidt S, Gavin A-C, Bork P, Serrano L: Transcriptome complexity in a genome-reduced bacterium. Science. 2009, 326: 1268-1271. 10.1126/science.1176951.
Dornenburg JE, Devita AM, Palumbo MJ, Wade JT: Widespread antisense transcription in Escherichia coli. mBio. 2010, 1: e00024–10-e00024–10.
Albrecht M, Sharma CM, Reinhardt R, Vogel J, Rudel T: Deep sequencing-based discovery of the Chlamydia trachomatis transcriptome. Nucleic Acids Res. 2010, 38: 868-877. 10.1093/nar/gkp1032.
Lasa I, Toledo-Arana A, Dobin A, Villanueva M, de los Mozos IR, Vergara-Irigaray M, Segura V, Fagegaltier D, Penadés JR, Valle J, Solano C, Gingeras TR: Genome-wide antisense transcription drives mRNA processing in bacteria. Proc Natl Acad Sci U S A. 2011, 108: 20172-20177. 10.1073/pnas.1113521108.
Rasmussen S, Nielsen HB, Jarmer H: The transcriptionally active regions in the genome of Bacillus subtilis. Mol Microbiol. 2009, 73: 1043-1057. 10.1111/j.1365-2958.2009.06830.x.
Stougaard P, Molin S, Nordström K: RNAs involved in copy-number control and incompatibility of plasmid R1. Proc Natl Acad Sci. 1981, 78: 6008-6012. 10.1073/pnas.78.10.6008.
Tomizawa J, Itoh T, Selzer G, Som T: Inhibition of ColE1 RNA primer formation by a plasmid-specified small RNA. Proc Natl Acad Sci. 1981, 78: 1421-1425. 10.1073/pnas.78.3.1421.
Light J, Molin S: Post-transcriptional control of expression of the repa gene of plasmid-R1 mediated by a small Rna molecule. EMBO J. 1983, 2: 93-98.
Brantl S: Regulatory mechanisms employed by cis-encoded antisense RNAs. Curr Opin Microbiol. 2007, 10: 102-109. 10.1016/j.mib.2007.03.012.
Thomason MK, Storz G: Bacterial antisense RNAs: How many Are there, and what Are they doing?. Annu Rev Genet. 2010, 44: 167-188. 10.1146/annurev-genet-102209-163523.
Silby MW, Levy SB: Overlapping protein-encoding genes in Pseudomonas fluorescens p f0–1. PLoS Genet. 2008, 4: e1000094-10.1371/journal.pgen.1000094.
Sayed N, Jousselin A, Felden B: A cis-antisense RNA acts in trans in Staphylococcus aureus to control translation of a human cytolytic peptide. Nat Struct Mol Biol. 2012, 19: 105-112.
Arnvig KB, Young DB: Identification of small RNAs in Mycobacterium tuberculosis. Mol Microbiol. 2009, 73: 397-408. 10.1111/j.1365-2958.2009.06777.x.
Mandin P, Gottesman S: Integrating anaerobic/aerobic sensing and the general stress response through the ArcZ small RNA. EMBO J. 2010, 29: 3094-3107. 10.1038/emboj.2010.179.
Papenfort K, Said N, Welsink T, Lucchini S, Hinton JCD, Vogel J: Specific and pleiotropic patterns of mRNA regulation by ArcZ, a conserved, Hfq-dependent small RNA. Mol Microbiol. 2009, 74: 139-158. 10.1111/j.1365-2958.2009.06857.x.
Mandin P, Repoila F, Vergassola M, Geissmann T, Cossart P: Identification of new noncoding RNAs in Listeria monocytogenes and prediction of mRNA targets. Nucleic Acids Res. 2007, 35: 962-974. 10.1093/nar/gkl1096.
Chernick WS, Barbero GJ: Composition of tracheobronchial secretions in cystic fibrosis of the pancreas and bronchiectasis. Pediatrics. 1959, 24: 739-745.
Matthews LW, Spector S, Lemm J: Studies on pulmonary secretions. The over-all chemical composition of pulmonary secretions from patients with cystic fibrosis, bronchiectasis, and laryngectomy. Am Rev Respir Dis. 1963, 88: 199-204.
Hull J, Vervaart P, Grimwood K, Phelan P: Pulmonary oxidative stress response in young children with cystic fibrosis. Thorax. 1997, 52: 557-560. 10.1136/thx.52.6.557.
Brown RK, Kelly FJ: Evidence for increased oxidative damage in patients with cystic fibrosis. Pediatr Res. 1994, 36: 487-493. 10.1203/00006450-199410000-00013.
Cantin A: Cystic fibrosis lung inflammation: early, sustained, and severe. Am J Respir Crit Care Med. 1995, 151: 939-941.
Frederiksen B, Lanng S, Koch C, Hoiby N: Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment. Pediatr Pulmonol. 1996, 21: 153-158. 10.1002/(SICI)1099-0496(199603)21:3<153::AID-PPUL1>3.0.CO;2-R.
Ferrara S, Brugnoli M, De Bonis A, Righetti F, Delvillani F, Dehò G, Horner D, Briani F, Bertoni G: Comparative profiling of Pseudomonas aeruginosa strains reveals differential expression of novel unique and conserved small RNAs. PLoS One. 2012, 7: e36553-10.1371/journal.pone.0036553.
Wurtzel O, Yoder-Himes DR, Han K, Dandekar AA, Edelheit S, Greenberg EP, Sorek R, Lory S: The single-nucleotide resolution transcriptome of Pseudomonas aeruginosa grown in body temperature. PLoS Pathog. 2012, 8: e1002945-10.1371/journal.ppat.1002945.
Saiman L, Marshall BC, Mayer-Hamblett N, Burns JL, Quittner AL, Cibene DA, Coquillette S, Fieberg AY, Accurso FJ, Campbell PW, Macrolide Study Group: Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA. 2003, 290: 1749-1756. 10.1001/jama.290.13.1749.
Doring G, Conway SP, Heijerman HG, Hodson ME, Hoiby N, Smyth A, Touw DJ: Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J. 2000, 16: 749-767. 10.1034/j.1399-3003.2000.16d30.x.
Aronoff SC, Klinger JD: In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosis. Antimicrob Agents Chemother. 1984, 25: 279-280. 10.1128/AAC.25.2.279.
Szaff M, Hoiby N, Flensborg EW: Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection. Acta Paediatr Scand. 1983, 72: 651-657. 10.1111/j.1651-2227.1983.tb09789.x.
Høiby N: Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis. BMC Med. 2011, 9: 32-10.1186/1741-7015-9-32.
Gómez-Lozano M, Marvig RL, Molin S, Long KS: Genome-wide identification of novel small RNAs in Pseudomonas aeruginosa. Environ Microbiol. 2012, 14: 2006-2016. 10.1111/j.1462-2920.2012.02759.x.
Gómez-Lozano M, Marvig RL, Molin S, Long KS: Identification of bacterial small RNAs by RNA sequencing. Pseudomonas Methods and Protocols. 2014, New York, NY: Springer Science+Business Media New York, 1149: 433-456. 10.1007/978-1-4939-0473-0_34. Methods in Molecular Biology
Carter MQ, Chen J, Lory S: The Pseudomonas aeruginosa pathogenicity island PAPI-1 is transferred via a novel type IV pilus. J Bacteriol. 2010, 192: 3249-3258. 10.1128/JB.00041-10.
Cirz RT, O’Neill BM, Hammond JA, Head SR, Romesberg FE: Defining the Pseudomonas aeruginosa SOS response and its role in the global response to the antibiotic ciprofloxacin. J Bacteriol. 2006, 188: 7101-7110. 10.1128/JB.00807-06.
Rocchetta HL, Burrows LL, Lam JS: Genetics of O-antigen biosynthesis in Pseudomonas aeruginosa. Microbiol Mol Biol Rev. 1999, 63: 523-553.
Larkin A, Imperiali B: Biosynthesis of UDP-GlcNAc(3NAc)A by WbpB, WbpE, and WbpD: enzymes in the Wbp pathway responsible for O-antigen assembly in Pseudomonas aeruginosa PAO1. Biochemistry. 2009, 48: 5446-5455. 10.1021/bi900186u.
Bordi C, Lamy MC, Ventre I, Termine E, Hachani A, Fillet S, Roche B, Bleves S, Mejean V, Lazdunski A, Filloux A: Regulatory RNAs and the HptB/RetS signalling pathways fine‒tune Pseudomonas aeruginosa pathogenesis. Mol Microbiol. 2010, 76: 1427-1443. 10.1111/j.1365-2958.2010.07146.x.
Kay E, Dubuis C, Haas D: Three small RNAs jointly ensure secondary metabolism and biocontrol in Pseudomonas fluorescens CHA0. Proc Natl Acad Sci. 2005, 102: 17136-17141. 10.1073/pnas.0505673102.
Gottesman S, Storz G: Bacterial small RNA regulators: versatile roles and rapidly evolving variations. Cold Spring Harb Perspect Biol. 2011, 3: a00379-
Hafner M, Renwick N, Brown M, Mihailović A, Holoch D, Lin C, Pena JTG, Nusbaum JD, Morozov P, Ludwig J, Ojo T, Luo S, Schroth G, Tuschl T: RNA-ligase-dependent biases in miRNA representation in deep-sequenced small RNA cDNA libraries. RNA. 2011, 17: 1697-1712. 10.1261/rna.2799511.
Zhuang F, Fuchs RT, Sun Z, Zheng Y, Robb GB: Structural bias in T4 RNA ligase-mediated 3’-adapter ligation. Nucleic Acids Res. 2012, 40: e54-e54. 10.1093/nar/gkr1263.
Jayaprakash AD, Jabado O, Brown BD, Sachidanandam R: Identification and remediation of biases in the activity of RNA ligases in small-RNA deep sequencing. Nucleic Acids Res. 2011, 39: e141-e141. 10.1093/nar/gkr693.
Munafó DB, Robb GB: Optimization of enzymatic reaction conditions for generating representative pools of cDNA from small RNA. RNA. 2010, 16: 2537-2552. 10.1261/rna.2242610.
Taube R, Loya S, Avidan O, Perach M, Hizi A: Reverse transcriptase of mouse mammary tumour virus: expression in bacteria, purification and biochemical characterization. Biochem J. 1998, 332 (Pt 3): 807-808.
Sendler E, Johnson GD, Krawetz SA: Local and global factors affecting RNA sequencing analysis. Anal Biochem. 2011, 419: 317-322. 10.1016/j.ab.2011.08.013.
Dabney J, Meyer M: Length and GC-biases during sequencing library amplification: a comparison of various polymerase-buffer systems with ancient and modern DNA sequencing libraries. Biotechniques. 2012, 52: 87-94.
Linsen SEV, de Wit E, Janssens G, Heater S, Chapman L, Parkin RK, Fritz B, Wyman SK, de Bruijn E, Voest EE, Kuersten S, Tewari M, Cuppen E: Limitations and possibilities of small RNA digital gene expression profiling. Nat Meth. 2009, 6: 474-476. 10.1038/nmeth0709-474.
Baker M: MicroRNA profiling: separating signal from noise. Nat Meth. 2010, 7: 687-692. 10.1038/nmeth0910-687.
Langmead B, Salzberg SL: Fast gapped-read alignment with Bowtie 2. Nat Meth. 2012, 9: 357-359. 10.1038/nmeth.1923.
Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R: The sequence alignment/map format and SAMtools. Bioinformatics. 2009, 25: 2078-2079. 10.1093/bioinformatics/btp352.
We gratefully acknowledge Paula Tribelli for experimental assistance and for revising the manuscript. This work was supported by the Novo Nordisk Foundation and the Danish National Research Agency.
The authors declare that they have no competing interests.
MGL participated in the design of the study, carried out the RNA-seq experiments, participated in the data analysis and drafted the manuscript. RLM participated in the data analysis. MVLT carried out the RACE experiments. SM participated in the design and coordination of the study and helped to draft the manuscript. All authors read and approved the final manuscript.